CN104547535A - Traditional Chinese medicine composition for treating nasopharyngitis - Google Patents
Traditional Chinese medicine composition for treating nasopharyngitis Download PDFInfo
- Publication number
- CN104547535A CN104547535A CN201510054267.3A CN201510054267A CN104547535A CN 104547535 A CN104547535 A CN 104547535A CN 201510054267 A CN201510054267 A CN 201510054267A CN 104547535 A CN104547535 A CN 104547535A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- herba
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicine composition for treating nasopharyngitis. The traditional Chinese medicine composition comprises the following substances in parts by weight: 10-30 parts of houttuynia cordata, 10-20 parts of flos magnoliae, 10-20 parts of cocklebur fruits, 10-20 parts of radix angelicae, 1-5 parts of asarum, 5-10 parts of liquorice, 10-15 parts of agastache rugosus, 6-12 parts of bile arisaema, 6-15 parts of fructus viticis, 10-20 parts of chrysanthemums, 10-20 parts of immature fruits of terminalia chebula, 10-20 parts of oroxylum indicum, 10-20 parts of platycodon grandiflorum, 10-15 parts of fructus arctii, 10-15 parts of radix saposhnikoviae, 10-20 parts of radix asparagi, 10-30 parts of radix ophiopogonis, 10-18 parts of moutan barks, 6-12 parts of scutellaria baicalensis and 6-12 parts of centipeda minima. The traditional Chinese medicine composition disclosed by the invention is capable of interacting and taking a synergistic effect, remarkable in curative effect and very worthy of being widely popularized.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition for the treatment of nasopharyngitis.
Background technology
Nasopharyngitis is clinical much, symptom similar to general pharyngolaryngitis (itch, pain, cough, drying, abundant expectoration not easily cough), lack specific findings, therefore for the case of main suit's bottleneck throat discomfort, show as bottleneck throat NIP or only swallow rear wall hyperemia, follicle hypertrophy, secretions attachment person, should consider to there is nasopharyngitis.Motherland's medical science thinks that nasopharynx part is " neck forehead ", but lacks understanding for nasopharyngitis ancients.Because anatomical structure is close with pharynx, tonsil etc., current Treatment with TCM nasopharyngitis defers to the sick rule for the treatment of such as anxious inflammation of the throat, tonsillitis more, thinks that nasopharyngitis is with deficiency of both QI and YIN, and asthenia of pulmonosplenic qi is this, the heresy invasion and attack of wind heat, wind and cold, and exuberant evil_heat is mark.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of nasopharyngitis.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of nasopharyngitis, it comprises the material of following weight portion: Herba Houttuyniae 10-30 part, Flos Magnoliae 10-20 part, Fructus Xanthii 10-20 part, Radix Angelicae Dahuricae 10-20 part, Herba Asari 1-5 part, Radix Glycyrrhizae 5-10 part, Herba Pogostemonis 10-15 part, Arisaema Cum Bile 6-12 part, Fructus Viticis 6-15 part, Flos Chrysanthemi 10-20 part, FRUCTUS TERMINALIAE IMMATURUS 10-20 part, Semen Oroxyli 10-20 part, Radix Platycodonis 10-20 part, Fructus Arctii 10-15 part, Radix Saposhnikoviae 10-15 part, Radix Asparagi 10-20 part, Radix Ophiopogonis 10-30 part, Cortex Moutan 10-18 part, Radix Scutellariae 6-12 part and Herba Centipedae 6-12 part.
Preferably, the Chinese medicine composition of described treatment nasopharyngitis comprises the material of following weight portion: Herba Houttuyniae 20 parts, Flos Magnoliae 15 parts, Fructus Xanthii 15 parts, the Radix Angelicae Dahuricae 15 parts, Herba Asari 3 parts, 8 parts, Radix Glycyrrhizae, Herba Pogostemonis 12 parts, Arisaema Cum Bile 10 parts, Fructus Viticis 10 parts, Flos Chrysanthemi 15 parts, FRUCTUS TERMINALIAE IMMATURUS 15 parts, Semen Oroxyli 15 parts, Radix Platycodonis 15 parts, Fructus Arctii 12 parts, Radix Saposhnikoviae 12 parts, Radix Asparagi 15 parts, Radix Ophiopogonis 20 parts, Cortex Moutan 15 parts, Radix Scutellariae 10 parts and Herba Centipedae 10 parts.
Preferably, the Chinese medicine composition of described treatment nasopharyngitis also comprises the material of following weight portion: Herba Cirrohopetali Andersonii 8 parts, Caulis Zizaniae caduciflorae 10 parts, Herba Scutellariae Sessilifoliae 9 parts, Rhizoma Paridis 5 parts, Fructus Gardeniae 15 parts, Fructus Lycii 10 parts, Calyx seu Fructus physalis 6 parts, blue 7 parts of fingernail, Herba lysimachiae capillipedis 6 parts, Flos Begoniae Evansianae 8 parts, Rhizoma Curcumae Longae grass 10 parts, Herb Gynostemmae Pentaphylli 15 parts, Flos jasmini 6 parts, Semen Raphani 3 parts and Flos Osmanthi Fragrantis 10 parts.
Preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, pill or nasal spray.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment nasopharyngitis, described compositions comprises the material of following weight portion: Herba Houttuyniae 10-30 part, Flos Magnoliae 10-20 part, Fructus Xanthii 10-20 part, Radix Angelicae Dahuricae 10-20 part, Herba Asari 1-5 part, Radix Glycyrrhizae 5-10 part, Herba Pogostemonis 10-15 part, Arisaema Cum Bile 6-12 part, Fructus Viticis 6-15 part, Flos Chrysanthemi 10-20 part, FRUCTUS TERMINALIAE IMMATURUS 10-20 part, Semen Oroxyli 10-20 part, Radix Platycodonis 10-20 part, Fructus Arctii 10-15 part, Radix Saposhnikoviae 10-15 part, Radix Asparagi 10-20 part, Radix Ophiopogonis 10-30 part, Cortex Moutan 10-18 part, Radix Scutellariae 6-12 part and Herba Centipedae 6-12 part.
Preferably, described compositions comprises the material of following weight portion: Herba Houttuyniae 20 parts, Flos Magnoliae 15 parts, Fructus Xanthii 15 parts, the Radix Angelicae Dahuricae 15 parts, Herba Asari 3 parts, 8 parts, Radix Glycyrrhizae, Herba Pogostemonis 12 parts, Arisaema Cum Bile 10 parts, Fructus Viticis 10 parts, Flos Chrysanthemi 15 parts, FRUCTUS TERMINALIAE IMMATURUS 15 parts, Semen Oroxyli 15 parts, Radix Platycodonis 15 parts, Fructus Arctii 12 parts, Radix Saposhnikoviae 12 parts, Radix Asparagi 15 parts, Radix Ophiopogonis 20 parts, Cortex Moutan 15 parts, Radix Scutellariae 10 parts and Herba Centipedae 10 parts.
Preferably, described compositions also comprises the material of following weight portion: Herba Cirrohopetali Andersonii 8 parts, Caulis Zizaniae caduciflorae 10 parts, Herba Scutellariae Sessilifoliae 9 parts, Rhizoma Paridis 5 parts, Fructus Gardeniae 15 parts, Fructus Lycii 10 parts, Calyx seu Fructus physalis 6 parts, blue 7 parts of fingernail, Herba lysimachiae capillipedis 6 parts, Flos Begoniae Evansianae 8 parts, Rhizoma Curcumae Longae grass 10 parts, Herb Gynostemmae Pentaphylli 15 parts, Flos jasmini 6 parts, Semen Raphani 3 parts and Flos Osmanthi Fragrantis 10 parts.
Preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, pill or nasal spray.
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 nasal spray of the present invention
Take Herba Houttuyniae 200 grams, Flos Magnoliae 150 grams, Fructus Xanthii 150 grams, the Radix Angelicae Dahuricae 150 grams, Herba Asari 30 grams, 80 grams, Radix Glycyrrhizae, Herba Pogostemonis 120 grams, Arisaema Cum Bile 100 grams, Fructus Viticis 100 grams, Flos Chrysanthemi 150 grams, FRUCTUS TERMINALIAE IMMATURUS 150 grams, Semen Oroxyli 150 grams, Radix Platycodonis 150 grams, Fructus Arctii 120 grams, Radix Saposhnikoviae 120 grams, Radix Asparagi 150 grams, Radix Ophiopogonis 200 grams, Cortex Moutan 150 grams, Radix Scutellariae 100 grams and Herba Centipedae 100 grams, pulverize, cross 100 mesh sieves, evenly be dispensed in 100 powder spray nose devices, obtain final product.
Embodiment 2 nasal spray of the present invention
Take Herba Houttuyniae 200 grams, Flos Magnoliae 150 grams, Fructus Xanthii 150 grams, the Radix Angelicae Dahuricae 150 grams, Herba Asari 30 grams, 80 grams, Radix Glycyrrhizae, Herba Pogostemonis 120 grams, Arisaema Cum Bile 100 grams, Fructus Viticis 100 grams, Flos Chrysanthemi 150 grams, FRUCTUS TERMINALIAE IMMATURUS 150 grams, Semen Oroxyli 150 grams, Radix Platycodonis 150 grams, Fructus Arctii 120 grams, Radix Saposhnikoviae 120 grams, Radix Asparagi 150 grams, Radix Ophiopogonis 200 grams, Cortex Moutan 150 grams, Radix Scutellariae 100 grams, Herba Centipedae 100 grams, Herba Cirrohopetali Andersonii 80 grams, Caulis Zizaniae caduciflorae 100 grams, Herba Scutellariae Sessilifoliae 90 grams, Rhizoma Paridis 50 grams, Fructus Gardeniae 150 grams, Fructus Lycii 100 grams, Calyx seu Fructus physalis 60 grams, blue 70 grams of fingernail, Herba lysimachiae capillipedis 60 grams, Flos Begoniae Evansianae 80 grams, Rhizoma Curcumae Longae grass 100 grams, Herb Gynostemmae Pentaphylli 150 grams, Flos jasmini 60 grams, Semen Raphani 30 grams and Flos Osmanthi Fragrantis 100 grams, pulverize, cross 100 mesh sieves, evenly be dispensed in 100 powder spray nose devices, obtain.
Experimental example
Diagnostic criteria reference " eye, OtorhinolaryngologicDiseases Diseases diagnostic criteria " (Shu Huai. eye, OtorhinolaryngologicDiseases Diseases diagnostic criteria. Beijing: Science Press, 2001:395) formulate.Take Postnasal drip as main manifestations: ictal or persistent cough appears in patient, cough mainly occurs in daytime, and nocturnal cough's symptom is slighter, Postnasal drip and pharynx rear wall mucus adhering sense, check that visible mucus is adhered to, outward appearance presents cobblestone sample, and CT examination eliminates sinusitis, nasal polyp, get rid of allergic rhinitis, without returning the performance of the esophageal reflux such as sour symptom and rear mucosa accumulation, endoscopy gets rid of adenoid vegetation, pharyngeal bursitis, nasopharynx part cobblestone sample hypertrophy, is diagnosed as nasopharyngitis.
According to above-mentioned standard, select 100 routine nasopharyngitis patients, wherein man 42 example, female 58 example, age 22-58 year, average 36 years old; Course of disease 0.5-12 month.Be two groups by patient, be respectively treatment group 1 and treatment group 2, often group has 50 routine patients.Two groups of Genders, age, the course of disease, symptom there are no significant difference, have comparability (P > 0.05).
Treatment group 1 uses the nasal spray of preparation in embodiment 1 to treat, every day twice, and each use nasal spray is evenly sprayed onto in two nostrils, continuously treatment 7 days.
Treatment group 2 uses the nasal spray of preparation in embodiment 2 to treat, every day twice, and each use nasal spray is evenly sprayed onto in two nostrils, continuously treatment 7 days.
Criterion of therapeutical effect
According to (Zheng Xiao cornel. new Chinese medicine guideline of clinical investigations (trying). Beijing: China Medical Science Press, 2002:332.) formulate criterion of therapeutical effect.Before and after treatment, total mark reduces >=2/3 is effective, and total mark reduces >=1/3 but is effectively less than 2/3, and it is invalid that total mark reduces <.
Statistical method
Utilize SPSS 13.0 software to process and analyze to experimental data, measurement data is with mean ± standard deviation
represent, adopt t inspection, enumeration data adopts x
2inspection, P < 0.05 represents that difference has statistical significance.
Result
Through treatment, for treatment group 1, effective 31 examples, effective 12 examples, invalid 7 examples, total effective rate is 86%, and for treatment group 2, effective 36 examples, effective 13 examples, invalid 1 example, total effective rate is 98%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).
Untoward reaction and toxic and side effects supervision
By detect patient blood pressure, pulse, whether there is Nausea and vomiting, dizzy clinical symptoms judges untoward reaction.Find that the systolic pressure of all patients is between 90-140mmHg, diastolic pressure is between 60-90mmHg, and pulse is 60-100 beat/min, and blood pressure and pulse all within normal range, and does not occur Nausea and vomiting, dizzy clinical symptoms.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that medicine does not have obvious toxic and side effects for human body.
Claims (8)
1. treat the Chinese medicine composition of nasopharyngitis for one kind, it is characterized in that, it comprises the material of following weight portion: Herba Houttuyniae 10-30 part, Flos Magnoliae 10-20 part, Fructus Xanthii 10-20 part, Radix Angelicae Dahuricae 10-20 part, Herba Asari 1-5 part, Radix Glycyrrhizae 5-10 part, Herba Pogostemonis 10-15 part, Arisaema Cum Bile 6-12 part, Fructus Viticis 6-15 part, Flos Chrysanthemi 10-20 part, FRUCTUS TERMINALIAE IMMATURUS 10-20 part, Semen Oroxyli 10-20 part, Radix Platycodonis 10-20 part, Fructus Arctii 10-15 part, Radix Saposhnikoviae 10-15 part, Radix Asparagi 10-20 part, Radix Ophiopogonis 10-30 part, Cortex Moutan 10-18 part, Radix Scutellariae 6-12 part and Herba Centipedae 6-12 part.
2. the Chinese medicine composition for the treatment of nasopharyngitis according to claim 1, it is characterized in that, it comprises the material of following weight portion: Herba Houttuyniae 20 parts, Flos Magnoliae 15 parts, Fructus Xanthii 15 parts, the Radix Angelicae Dahuricae 15 parts, Herba Asari 3 parts, 8 parts, Radix Glycyrrhizae, Herba Pogostemonis 12 parts, Arisaema Cum Bile 10 parts, Fructus Viticis 10 parts, Flos Chrysanthemi 15 parts, FRUCTUS TERMINALIAE IMMATURUS 15 parts, Semen Oroxyli 15 parts, Radix Platycodonis 15 parts, Fructus Arctii 12 parts, Radix Saposhnikoviae 12 parts, Radix Asparagi 15 parts, Radix Ophiopogonis 20 parts, Cortex Moutan 15 parts, Radix Scutellariae 10 parts and Herba Centipedae 10 parts.
3. the Chinese medicine composition for the treatment of nasopharyngitis according to claim 1 and 2, it is characterized in that, it also comprises the material of following weight portion: Herba Cirrohopetali Andersonii 8 parts, Caulis Zizaniae caduciflorae 10 parts, Herba Scutellariae Sessilifoliae 9 parts, Rhizoma Paridis 5 parts, Fructus Gardeniae 15 parts, Fructus Lycii 10 parts, Calyx seu Fructus physalis 6 parts, blue 7 parts of fingernail, Herba lysimachiae capillipedis 6 parts, Flos Begoniae Evansianae 8 parts, Rhizoma Curcumae Longae grass 10 parts, Herb Gynostemmae Pentaphylli 15 parts, Flos jasmini 6 parts, Semen Raphani 3 parts and Flos Osmanthi Fragrantis 10 parts.
4. the Chinese medicine composition for the treatment of nasopharyngitis according to claim 3, is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, pill or nasal spray.
5. the purposes of compositions in the Chinese medicine of preparation treatment nasopharyngitis, it is characterized in that, described compositions comprises the material of following weight portion: Herba Houttuyniae 10-30 part, Flos Magnoliae 10-20 part, Fructus Xanthii 10-20 part, Radix Angelicae Dahuricae 10-20 part, Herba Asari 1-5 part, Radix Glycyrrhizae 5-10 part, Herba Pogostemonis 10-15 part, Arisaema Cum Bile 6-12 part, Fructus Viticis 6-15 part, Flos Chrysanthemi 10-20 part, FRUCTUS TERMINALIAE IMMATURUS 10-20 part, Semen Oroxyli 10-20 part, Radix Platycodonis 10-20 part, Fructus Arctii 10-15 part, Radix Saposhnikoviae 10-15 part, Radix Asparagi 10-20 part, Radix Ophiopogonis 10-30 part, Cortex Moutan 10-18 part, Radix Scutellariae 6-12 part and Herba Centipedae 6-12 part.
6. purposes according to claim 5, it is characterized in that, described compositions comprises the material of following weight portion: Herba Houttuyniae 20 parts, Flos Magnoliae 15 parts, Fructus Xanthii 15 parts, the Radix Angelicae Dahuricae 15 parts, Herba Asari 3 parts, 8 parts, Radix Glycyrrhizae, Herba Pogostemonis 12 parts, Arisaema Cum Bile 10 parts, Fructus Viticis 10 parts, Flos Chrysanthemi 15 parts, FRUCTUS TERMINALIAE IMMATURUS 15 parts, Semen Oroxyli 15 parts, Radix Platycodonis 15 parts, Fructus Arctii 12 parts, Radix Saposhnikoviae 12 parts, Radix Asparagi 15 parts, Radix Ophiopogonis 20 parts, Cortex Moutan 15 parts, Radix Scutellariae 10 parts and Herba Centipedae 10 parts.
7. the purposes according to claim 5 or 6, it is characterized in that, described compositions also comprises the material of following weight portion: Herba Cirrohopetali Andersonii 8 parts, Caulis Zizaniae caduciflorae 10 parts, Herba Scutellariae Sessilifoliae 9 parts, Rhizoma Paridis 5 parts, Fructus Gardeniae 15 parts, Fructus Lycii 10 parts, Calyx seu Fructus physalis 6 parts, blue 7 parts of fingernail, Herba lysimachiae capillipedis 6 parts, Flos Begoniae Evansianae 8 parts, Rhizoma Curcumae Longae grass 10 parts, Herb Gynostemmae Pentaphylli 15 parts, Flos jasmini 6 parts, Semen Raphani 3 parts and Flos Osmanthi Fragrantis 10 parts.
8. purposes according to claim 7, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, pill or nasal spray.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510054267.3A CN104547535A (en) | 2015-02-03 | 2015-02-03 | Traditional Chinese medicine composition for treating nasopharyngitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510054267.3A CN104547535A (en) | 2015-02-03 | 2015-02-03 | Traditional Chinese medicine composition for treating nasopharyngitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104547535A true CN104547535A (en) | 2015-04-29 |
Family
ID=53065306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510054267.3A Pending CN104547535A (en) | 2015-02-03 | 2015-02-03 | Traditional Chinese medicine composition for treating nasopharyngitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104547535A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106601A (en) * | 2015-09-15 | 2015-12-02 | 全椒先奇医药科技有限公司 | Medicinal preparation for treating acute nasopharyngitis |
| CN105902995A (en) * | 2016-07-02 | 2016-08-31 | 王德利 | Traditional Chinese medicine preparation for treating nasopharyngitis and preparation method thereof |
| CN106138529A (en) * | 2016-07-28 | 2016-11-23 | 覃善杰 | A kind of for treating sick medicine of nasopharyngitis and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103394060A (en) * | 2013-07-27 | 2013-11-20 | 高星 | Medicament for treating rhinitis |
-
2015
- 2015-02-03 CN CN201510054267.3A patent/CN104547535A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103394060A (en) * | 2013-07-27 | 2013-11-20 | 高星 | Medicament for treating rhinitis |
Non-Patent Citations (1)
| Title |
|---|
| 马骏: "通鼻消炎球治疗鼻炎", 《四川中医》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106601A (en) * | 2015-09-15 | 2015-12-02 | 全椒先奇医药科技有限公司 | Medicinal preparation for treating acute nasopharyngitis |
| CN105902995A (en) * | 2016-07-02 | 2016-08-31 | 王德利 | Traditional Chinese medicine preparation for treating nasopharyngitis and preparation method thereof |
| CN106138529A (en) * | 2016-07-28 | 2016-11-23 | 覃善杰 | A kind of for treating sick medicine of nasopharyngitis and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341145B (en) | Traditional Chinese medicine for treating psoriasis and preparation method thereof | |
| CN103463539A (en) | Drug for treating eczema, and preparation method and use thereof | |
| CN102319294B (en) | Double-vanilla preparation and preparation method thereof | |
| CN102805776B (en) | Traditional Chinese medicine composition and preparation method of traditional Chinese medicine composition | |
| CN104547535A (en) | Traditional Chinese medicine composition for treating nasopharyngitis | |
| CN102657785B (en) | Medicinal composition for treating gingivitis | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN114767824B (en) | Preparation for treating laryngeal cough and preparation method thereof | |
| CN102657709B (en) | A traditional Chinese medicine for treating rhinitis | |
| CN103690789B (en) | A kind of Chinese medicine preparation for the treatment of radioactive stomatitis | |
| CN105497291A (en) | Medicine composition for treating schizophrenia | |
| CN102327451B (en) | Chinese medicinal composition for treating chronic sinusitis | |
| CN103142983A (en) | Medicament for treating chronic pharyngitis | |
| CN103157091A (en) | Drug for treating empyrosis | |
| CN103142978A (en) | Medicine for treating peripheral facial paralysis | |
| CN101259165A (en) | Chaihuang preparations and producing method thereof | |
| CN102973856B (en) | Anti-cold pharmaceutical composition and preparation method thereof | |
| CN102671069B (en) | Medicinal composition for treating allergic rhinitis | |
| CN106166273A (en) | A kind of otorhinolaryngology nursing medicine for external use and preparation method thereof | |
| CN105311598A (en) | Semen Trichosanthis Kirilowii medicinal composition for treating chronic pharyngitis and preparation method thereof | |
| CN101502597A (en) | Medicament for treating stomachache and preparation method thereof | |
| CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
| CN105434890A (en) | Radiation stomatitis treating traditional Chinese medicine composition | |
| CN106177686A (en) | A kind of Chinese medicine for treating urticaria | |
| CN106109927A (en) | A kind of pharmaceutical composition treating chloasma and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |
|
| RJ01 | Rejection of invention patent application after publication |